Life Sciences: Innovation and Compliance with Process Automation

Unlock the Full Potential of Life Sciences with Artsyl Intelligent Process Automation

In the highly regulated, data-intensive world of life sciences, efficiency and accuracy are non-negotiable. Whether you’re in pharmaceuticals, biotech, diagnostics, or food and beverage, managing vast amounts of paper and digital documents can slow you down - costing time, money, and compliance risks. Fortunately, process automation and AI-powered digital data extraction come to the rescue.

Artsyl’s Intelligent Process Automation (IPA) is here to change that.

Transform Data Chaos into Actionable Insights

Artsyl leverages machine learning-powered intelligent process automation and data extraction to capture information trapped in scanned paper and digital documents. Ultimately, it transforms the relevant business records into real-time, actionable data. With intelligent data capture, documents are automatically:

• Validated against internal databases or ERP systems
• Routed for seamless approvals
• Monitored to track bottlenecks and inefficiencies

This means no more manual data entry, no more lost time chasing down documents, and no more errors slipping through the cracks.

Why It Matters: The Numbers Speak for Themselves

• 41% of life science companies report that manual processes are their biggest barrier to operational efficiency.
• Businesses that implement intelligent automation see an average 30-50% reduction in processing time and up to 80% fewer manual errors.
• The global Intelligent Process Automation market is projected to grow to $21.3 billion by 2028, driven by the life sciences sector’s need for compliance and efficiency.

What Artsyl Brings to Life Sciences

Artsyl docAlpha IPA solutions streamline mission-critical processes by automating the most time-consuming steps, including:

The Artsyl Advantage: Faster, Smarter, Compliant

With Artsyl, life science companies can:

• Accelerate time-to-market by reducing document processing delays
• Ensure compliance with regulations like FDA’s 21 CFR Part 11 and EU Annex 11
• Improve decision-making with faster access to accurate data
• Cut operational costs while boosting productivity

Ready to streamline your operations, improve compliance, and unlock the true potential of your data? docAlpha Intelligent Process Automation is your key to driving growth and innovation in the life sciences industry.

Revolutionize Life Sciences with Artsyl’s docAlpha Digital Transformation Platform

In the fast-paced, highly regulated world of life sciences, the ability to manage paper and electronic records efficiently isn’t just a bonus - it’s essential for driving innovation and ensuring compliance.

From research and development to HR onboarding and applicant tracking, and from purchase order processing to quality assurance, Artsyl’s docAlpha Digital Transformation Platform delivers intelligent automation solutions that transform how life sciences companies operate.

Simplify Compliance, Accelerate Innovation

With Artsyl’s intelligent process automation (IPA), built on the powerful docAlpha platform, life sciences companies can streamline mission-critical functions while staying compliant with regulations like FDA’s 21 CFR Part 11 and the EU’s Annex 11. Whether you’re handling clinical trial documents, quality assurance data, or sales orders, docAlpha empowers you to automate workflows across departments for maximum efficiency and integrate seamlessly with ERPs like Acumatica and NetSuite, and ECMs for unified data management

End-to-End Process Automation for Every Life Sciences Department

In the highly regulated and data-intensive world of life sciences, manual processes can slow innovation, introduce errors, and put compliance at risk.

End-to-end process automation transforms how life sciences companies manage everything from manufacturing to financial operations, ensuring streamlined workflows, improved accuracy, and enhanced regulatory compliance. By automating critical functions, organizations can focus on innovation and growth while maintaining the highest standards of quality and efficiency.

Here’s how end-to-end process automation can revolutionize key areas in life sciences:

Accelerate R&D with Automated Document Management

Managing research documents, protocols, Case Report Forms (CRFs), and study tagging files can be time-consuming and prone to errors, putting clinical trial timelines at risk. End-to-end automation streamlines the organization and validation of these critical documents, ensuring they are always compliant and ready for submission.

By automating document management, life sciences companies can simplify clinical trial applications and approvals, reduce administrative burdens, and accelerate the time-to-market for new products. This not only speeds up the R&D process but also ensures regulatory readiness, minimizing delays and maximizing innovation potential.

By integrating real-time data capture and automated quality checks into the manufacturing process, companies can quickly identify and address issues, minimizing the risk of product recalls or regulatory non-compliance.

The result? Faster time-to-market, enhanced product safety, and improved regulatory audit readiness.

Accelerate Revenue Cycles with Automated Billing Processes

Manual billing processes can lead to errors, delays, and lost revenue opportunities. End-to-end automation ensures accurate invoice generation, automated approvals, and seamless integration with ERP systems like NetSuite and Acumatica.

By reducing manual data entry and eliminating discrepancies between sales orders and invoices, life sciences companies can accelerate cash flow and reduce the risk of billing errors. Automation also enables real-time visibility into the billing process, improving financial oversight and ensuring that revenue recognition aligns with industry standards and regulations.

Improve Cash Flow with Automated Collections Management

Timely collections are critical to maintaining healthy cash flow, but manual follow-ups can be time-consuming and inefficient. Automation streamlines the collections process by sending automated payment reminders, tracking outstanding invoices, and escalating overdue accounts without manual intervention.

By reducing Days Sales Outstanding (DSO), life sciences companies can enhance liquidity, improve financial forecasting, and allocate resources more effectively.

Reduce Costs and Improve Accuracy with Automated Payables

Managing accounts payable manually can be prone to errors, delays, and compliance risks. End-to-end automation simplifies the processing of invoices, purchase orders, and vendor payments by automating data capture, approval workflows, and payment scheduling.

With intelligent automation, life sciences companies can reduce invoice processing costs by up to 80%, eliminate duplicate payments, and take advantage of early payment discounts. Additionally, automation ensures that all transactions are compliant with internal controls and regulatory requirements, enhancing audit readiness and financial transparency.

By implementing end-to-end process automation, life sciences companies can achieve operational excellence across manufacturing and financial functions. This not only improves efficiency and compliance but also frees up valuable resources to focus on innovation and growth.

Why Artsyl’s docAlpha Stands Out

With docAlpha, you can automatically feed data from one process to another (e.g., CAPA to Change Control) to minimize manual intervention and eliminate redundancies. By institutionalizing compliance policies and procedures with intelligent automation, it’s easy to ensure all documentation meets industry standards.

From accounts payable automation to clinical trial management, docAlpha’s intelligent document processing capabilities enhance efficiency across every department.

Proven Results That Drive Growth

• Companies leveraging Artsyl docAlpha have seen up to 80% reductions in processing costs and significantly improved cycle times across departments.
• Automated sales and purchase order processing minimizes errors, accelerates approvals, and improves cash flow visibility.

Ready to transform your life sciences operations? Artsyl’s docAlpha Digital Transformation Platform empowers your teams to innovate faster, stay compliant, and drive sustainable growth - all while reducing operational costs. Let’s streamline your processes and take your business to the next level. Contact your Artsyl sales representative to get started today!

Want to Understand Process Automation in Life Sciences Better? What You Need to Know

Process automation intersects with regulatory compliance in the life sciences sector, ensuring both operational efficiency and adherence to global standards. Here are key aspects to remember.

What Is FDA’s 21 CFR Part 11?

This regulation by the U.S. Food and Drug Administration (FDA) establishes criteria for the acceptance of electronic records and electronic signatures as equivalent to paper records and handwritten signatures. It outlines requirements for data integrity, security, and audit trails in regulated environments like pharmaceuticals and biotech.

Any process automation involving electronic data in life sciences must ensure compliance with 21 CFR Part 11 to maintain regulatory approval and avoid costly penalties.

What Is EU’s Annex 11?

Annex 11 is part of the European Union’s Good Manufacturing Practices (GMP) guidelines, focusing on the use of computerized systems in pharmaceutical manufacturing and quality control. It covers aspects like system validation, data integrity, access control, and risk.

Life science companies operating in or exporting to the EU must ensure that their automated systems meet Annex 11 requirements to maintain market access and ensure product quality.

You may also like

Payment Processing: Transaction Lifecycle Payments Automation Software: Automated Payment Software Benefits Inventory Management: Harnessing the Power of Automated Workflows Process Automation: Driving Business Growth with Technology Business Process Automation: Examples, Tips, Technologies Machine Learning Algorithms in Business Process Automation

What Is the Value of Electronic Batch Record (EBR)?

An Electronic Batch Record (EBR) system digitizes the traditional paper-based process of documenting manufacturing batches. It automatically records critical data, ensuring compliance with GMP standards and reducing human error.

Automating batch records streamlines production, reduces the risk of non-compliance, and enhances traceability in regulated environments.

Why to Set Up Computer System Validation (CSV)

CSV is the process of ensuring that computerized systems used in life sciences perform as intended and comply with regulatory standards like 21 CFR Part 11 and Annex 11. This includes rigorous testing, documentation, and risk assessments.

Any automated process in the life sciences must undergo CSV to prove that it consistently produces accurate, reliable data, critical for product safety and regulatory audits.

Contact Us for an in-depth
product tour!

What Is an Audit Trail?

An audit trail is a secure, time-stamped log that tracks all changes to electronic data, including who made the change, what was changed, and when. This is a fundamental requirement for both 21 CFR Part 11 and Annex 11.

Automated processes must include robust audit trails to ensure data integrity, support regulatory compliance, and provide transparency during inspections or audits.